In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1832 News Items found
FDA Announces First Approval of Targeted Therapy Based on Basket Study

The US Food and Drug Administration (FDA) has announced that it has approved the drug vemurafenib for the treatment of patients with BRAF V600-mutant Erdheim-Chester disease (ECD). This is the first approval of a targeted therapy based on a basket study and the first-ever drug approved for ECD, a rare blood disorder. This landmark approval came as a direct result of research at Memorial Sloan Kettering Cancer Center (MSK).
In the Lab
iron-filled macrophages from a breast cancer tumor
MSK-Developed Technology Provides a “Virtual Biopsy” of Immune Cells in Tumors

The noninvasive approach could help scientists track the movements of an important cell type that can influence the outcome of cancer treatment.
Science Byte
Cancer biologist and pediatric oncologist Alex Kentsis
Blocking Enzymes That Signal DNA Damage Could Be a Treatment Strategy for Childhood Cancers

A new strategy for treating pediatric cancers involves preventing cells from repairing their own DNA.
Event
Shawn, a Fred’s Team runner
Why They Run: Fred’s Team Runners Take on the 2017 TCS New York City Marathon

Hear from five Fred’s Team members about why they’re running the New York City Marathon in 2017.
Q&A
MSK Integrative Medicine meditation instructor Emily Herzlin
How Meditation Can Help Those Affected by Cancer: At Work with Emily Herzlin

Meet Emily Herzlin, who teaches mindfulness and meditation at Memorial Sloan Kettering.
Finding
A new study suggests that healthcare providers should consider looking for monoclonal gammopathy of undetermined significance (MGUS) in younger African Americans.
Myeloma Precursor Disease Can Start Much Earlier than Expected, Especially in African Americans

New research has found that a precancerous blood condition can linger undetected for more than 20 years.
Announcement
Memorial Sloan Kettering medical oncologist Paul Hamlin
FDA Approves CAR T Cell Therapy for Non-Hodgkin Lymphoma

This is the second regulatory approval of the cell-based immunotherapy for a blood cancer.
In the Lab
Stem cells induced to become cardiomyocytes
Stem Cell Research Probes Why a Breast Cancer Treatment Sometimes Damages the Heart

Investigators are looking at how and why the breast cancer drug trastuzumab sometimes causes long-lasting and potentially serious cardiac side effects.
Q&A
MSK woman
The Benefits of a Metastatic Breast Cancer Support Group: An Interview with a Social Worker

Learn how a support group could help you if you’ve been diagnosed with metastatic breast cancer.
In the Lab
A micrograph image of breast cancer cells.
Research Reveals How Sleeping Cancer Cells Wake Up

MSK investigators are studying how dormant cancer cells can become reactivated after remaining hidden in the body for years.